Evidence map›Paper›PMID 35408647›Full record

ArticleMolecules (Basel, Switzerland)2022

Continuous Production of Highly Tuned Silk/Calcium-Based Composites: Exploring New Pathways for Skin Regeneration.

Anabela Veiga, Rui Magalhães, Marta M Duarte, Juliana R Dias, Nuno M Alves, Ana Rita Costa-Pinto, Filipa Castro, Fernando Rocha, Ana L Oliveira

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Anabela VeigaCBQF-Centro de Biotecnologia e Química Fina-Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal.ORCID 0000-0002-5677-9629
Rui MagalhãesCBQF-Centro de Biotecnologia e Química Fina-Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal.
Marta M DuarteCBQF-Centro de Biotecnologia e Química Fina-Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal.
Juliana R DiasALiCE-Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal.ORCID 0000-0002-7079-1069
Nuno M AlvesCentre for Rapid and Sustainable Product Development, Instituto Politécnico de Leiria, 2430-028 Marinha Grande, Portugal.ORCID 0000-0002-5016-0868
Ana Rita Costa-Pintoi3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal.ORCID 0000-0002-4764-8539
Filipa CastroLaboratory for Process Engineering, Environment, Biotechnology & Energy, Department of Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal.
Fernando RochaLaboratory for Process Engineering, Environment, Biotechnology & Energy, Department of Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal.ORCID 0000-0002-2778-8374
Ana L OliveiraCBQF-Centro de Biotecnologia e Química Fina-Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal.
Universidade do Porto · PTUniversidade Católica Portuguesa · PTInstituto Politécnico de Leiria · PT

Funding

Bone2Move POCI-01-0145-FEDER-31146CENTRO-01-0145-FEDER-000014-3362 MATISFundação para a Ciência e Tecnologia 2020.08683.BDFundação para a Ciência e Tecnologia UIDB/00511/2020Fundação para a Ciência e Tecnologia UIDB/04044/2020Fundação para a Ciência e Tecnologia UIDB/50016/2020Fundação para a Ciência e Tecnologia UIDP/04044/2020PAMI-ROTEIRO/0328/2013 Nº 022158
6 · The paper itself

Abstract

Calcium plays an important role in barrier function repair and skin homeostasis. In particular, calcium phosphates (CaPs) are well established materials for biomedical engineering due to their biocompatibility. To generate biomaterials with a more complete set of biological properties, previously discarded silk sericin (SS) has been recovered and used as a template to grow CaPs. Crucial characteristics for skin applications, such as antibacterial activity, can be further enhanced by doping CaPs with cerium (Ce) ions. The effectiveness of cell attachment and growth on the materials highly depends on their morphology, particle size distribution, and chemical composition. These characteristics can be tailored through the application of oscillatory flow technology, which provides precise mixing control of the reaction medium. Thus, in the present work, CaP/SS and CaP/SS/Ce particles were fabricated for the first time using a modular oscillatory flow plate reactor (MOFPR) in a continuous mode. Furthermore, the biological behavior of both these composites and of previously produced pure CaPs was assessed using human dermal fibroblasts (HDFs). It was demonstrated that both CaP based with plate-shaped nanoparticles and CaP-SS-based composites significantly improved cell viability and proliferation over time. The results obtained represent a first step towards the reinvention of CaPs for skin engineering.

Indexed as

SericinsSilkBiocompatible MaterialsCalciumCalcium PhosphatesHumansSkinBiocompatible MaterialsCalciumCalcium PhosphatesSericinsSilkcalcium phosphate-based materials (CaP)cerium (Ce)human dermal fibroblasts (HDFs)modular oscillatory flow plate reactor (MOPR)silk sericin (SS)skin regeneration

Identifiers

PMID35408647
PMCPMC9000890
OpenAlexW4220690302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.